Technology

BRG drugs are a new family of therapeutic agents that, based on our preclinical study results, induce broad anticancer and antiviral effects.

They deliver two active ingredients:

(1) 2, -3(aminopropyl)amino ethane thiol (NCI nomenclature APAET)

(2) a thiol-PEG polymer that can be varied for each BRG drug

The first active ingredient is the active form of an older FDA approved drug that has reported, in the peer-reviewed literature, anticancer and antiviral effects.